Principal Financial Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,184
| Closed | -$2.72M | – | 2241 |
|
|
2025
Q1 | $2.72M | Buy |
81,184
+28
| +0% | +$939 | ﹤0.01% | 1714 |
|
|
2024
Q4 | $4.15M | Buy |
81,156
+3,447
| +4% | +$176K | ﹤0.01% | 1643 |
|
|
2024
Q3 | $3.97M | Buy |
77,709
+64,504
| +488% | +$3.3M | ﹤0.01% | 1633 |
|
|
2024
Q2 | $591K | Sell |
13,205
-1,771
| -12% | -$79.3K | ﹤0.01% | 1918 |
|
|
2024
Q1 | $701K | Sell |
14,976
-909
| -6% | -$42.6K | ﹤0.01% | 1923 |
|
|
2023
Q4 | $565K | Sell |
15,885
-1,416
| -8% | -$50.4K | ﹤0.01% | 1939 |
|
|
2023
Q3 | $515K | Buy |
17,301
+3,649
| +27% | +$109K | ﹤0.01% | 1943 |
|
|
2023
Q2 | $246K | Sell |
13,652
-336
| -2% | -$6.06K | ﹤0.01% | 2127 |
|
|
2023
Q1 | $225K | Buy |
13,988
+1,654
| +13% | +$26.6K | ﹤0.01% | 2153 |
|
|
2022
Q4 | $226K | Buy |
+12,334
| New | +$226K | ﹤0.01% | 2167 |
|
|
2022
Q1 | – | Sell |
-7,295
| Closed | -$207K | – | 2559 |
|
|
2021
Q4 | $207K | Buy |
+7,295
| New | +$207K | ﹤0.01% | 2353 |
|